ProKidney Corp. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested
ProKidney Corp. (PROK) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested of $1.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested · last filed 2026-08-10
- ProKidney Corp. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2026-06-30 was $19.00K, a 171.43% increase year-over-year.
- ProKidney Corp. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2026-03-31 was $1.66M, a 5.14% increase year-over-year.
- ProKidney Corp. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2025-06-30 was $7.00K.
- ProKidney Corp. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2025-03-31 was $1.57M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 6 month |
|---|---|---|
| 2026-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.68M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.66M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.58M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $1.57M 10-Q · filed 2026-05-15 |